# Neuroimaging MAO-B in Medication Free TR-MDD Using Novel Tracer

> **NCT02153281** · NA · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 8 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **OTHER:** phenelzine treatment

## Key facts

- **NCT ID:** NCT02153281
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153281, "Neuroimaging MAO-B in Medication Free TR-MDD Using Novel Tracer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02153281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*